Clinical Trial Update: To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating single infusions of amphotericin B lipid formulations for visceral leishmaniasis (Kala-azar) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Amphotericin B lipid complex (amphotericin B lipid complex)
• Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: Bharat Serums and Vaccines Limited | Conditions: Leishmaniasis, Visceral | Phase 3 | Status: COMPLETED